Navigation Links
Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008
Date:5/1/2008

Company to Provide Financial Guidance for Fiscal 2008 through 2010

PITTSBURGH, May 1 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) announced today that it will host a conference call and live webcast on Thursday, May 8, 2008, at 5 p.m. ET to provide a review of the first quarter ended March 31, 2008. The company also will provide updated financial guidance for fiscal 2008 through fiscal 2010 and an operational and integration update on Merck Generics, which the company acquired on Oct. 2, 2007. The company will release its financial results after the market closes May 8.

The dial-in number to access the May 8 call is 877-719-9810 or 719-325-4793 for international callers. A replay, available for approximately seven days, will be available at 888-203-1112 or 719-457-0820 for international callers with access pass code 4576196.

To access a live webcast of the May 8 call, please log on to Mylan's Web site (http://www.mylan.com) at least 15 minutes before the event is to begin to register and download or install any necessary software. A replay of the webcast will be available on http://www.mylan.com for approximately seven days.

Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest-and highest quality-product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information abou
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Mylan Declares Quarterly Preferred Stock Dividend
2. Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
3. Mylan Announces Final FDA Approval for Trandolapril Tablets
4. Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
5. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
6. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
7. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
8. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
9. Mylan Restores Availability of Generic Levothyroxine in Florida
10. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
11. Mylan Declares Quarterly Preferred Stock Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ealth™ announced today that Spectrum Health ...d Enterprise orthopedic templating solution and it... (PRWEB) November 27, 2009 -- Voyant...h (Grand Rapids, Michigan) has licensed its Trauma...its TraumaCad Extend workflow solution, to allow i...
(Date:11/27/2009)...st manufacturers who use medical load cells at the...llars by bringing in technology partner Flintec ea...ro-active medical manufacturers are calling in Fli...ir projects, ensuring that progress will not be co...lly outdated technology. , ...
(Date:11/26/2009)...ewswire/ -- With cold and flu season upon us, it,s... to control the spread of infections and avoid ill...eep ourselves healthy, but to avoid transmitting i..., CIC (certified in infection-control), nursing di...th at Hospital for Special Surgery (HSS) in Manhat...
(Date:11/26/2009)... of Americans living with diabetes will nearly dou...million in 2034. Over the same period, spending on...lion to $336 billion, even with no increase in the...niversity of Chicago report in the December issue ...iabetes covered by Medicare will rise from 8.2 mil...
(Date:11/26/2009)...y can lead to strains or worse , , THURS...ing wrong with stuffing your turkey full to bursti...th your suitcase as you pack for holiday trips. ,... U.S. hospital emergency rooms, doctors, offices, ...elated injuries, such as muscle strains, pulls and...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2
...e used a biochemical chip to explain the important... of yeast cells. The finding could lead to new can...rch team at The John Hopkins University, led by An...has solved a long-standing mystery of how a specif...
... the University at Buffalo and the University of U... aspirin can improve a woman's chances of becoming...// UB's portion of the study is funded by a $... past year. "In women who have had their fi...
... a key signaling protein in the brain during infan...scientists say. //According to findings published ...ptor protein for the chemical messenger serotonin ...for serotonin, a neurotransmitter, show anxiety-li...
...vation therapy may aggravate heart disease in pati...archers at Dana-Farber Cancer Institute. // A...te cancer. The study results were based on d...ate that oncologists should weigh the benefits of ...
...ical doctor who contracted Lassa fever in Nigeria ...a, //the Gauteng Department of Health said on Wedn...ation and is receiving treatment in the hospital's...ent was flown from Abuja in Nigeria on Monday, for...
...at Capital Health are extremely optimistic about t...iew to better management //of emergency care and r...the changes, a plan has been initiated to effectiv...atients who need to be shifted from emergency care...
Other Medicine News:Health News:Biochemical Chip Solves Cell-mating Puzzle 2Health News:Biochemical Chip Solves Cell-mating Puzzle 3Health News:Study to Look at Aspirin as Aid to Conception, Healthy Pregnancy 2Health News:Mouse Study Suggests Anxiety Disorders Take Root in Infancy 2Health News:Benefits of ADT Against Risk of Heart Ailments 2Health News:South Africa: Nigerian Man Treated for Lassa Fever 2
(Date:11/25/2009)... Regado Biosciences, a privately h...tic aptamers with active control agents, announced... presenting at the Piper Jaffray 21st Annual Healt...New York City. Dr. Mazzo,s presentation will be g...ll include an overview of the Company,s pipeline w...
(Date:11/25/2009)... 25 Swissray International, Inc. a...y ( ddR ) systems, announced today that its operat...r with a long term view towards growing Swissray,s...ll assets and intellectual property, as well as co...nd growth Swissray is now poised to move to the ne...
(Date:11/25/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Intranasal Drug Delivery - US Market Tre...0164267/Intranasal-Drug-Delivery---US-Market-Trend...ivery market is witnessing an expansion of therape...l local therapeutic drugs to the delivery of syste...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Pelosi House Leaders Committee Chairs Remarks at Press Conference on Americas Affordable Health Choices Act 52032 1Pelosi House Leaders Committee Chairs Remarks at Press Conference on Americas Affordable Health Choices Act 52032 2Pelosi House Leaders Committee Chairs Remarks at Press Conference on Americas Affordable Health Choices Act 52032 3Pelosi House Leaders Committee Chairs Remarks at Press Conference on Americas Affordable Health Choices Act 52032 4Pelosi House Leaders Committee Chairs Remarks at Press Conference on Americas Affordable Health Choices Act 52032 5Pelosi House Leaders Committee Chairs Remarks at Press Conference on Americas Affordable Health Choices Act 52032 6Pelosi House Leaders Committee Chairs Remarks at Press Conference on Americas Affordable Health Choices Act 52032 7Biopure Corporation Receives Notice of Delisting from Nasdaq 52027 1Compirion Healthcare Sponsors Webinar on 7 Mistakes That Lower Patient Satisfaction Scores 52022 1Compirion Healthcare Sponsors Webinar on 7 Mistakes That Lower Patient Satisfaction Scores 52022 2Compirion Healthcare Sponsors Webinar on 7 Mistakes That Lower Patient Satisfaction Scores 52022 3
...an improve memory and attention by training on com...presented today at the annual meeting of the Ameri...ski, PhD, lead investigator on the study and a pro... also reported on new data showing that the gains ...tal of 487 healthy adults over the age of 65 parti...
... 30 An innovative treatment for,infections of the... received,orphan drug designation in the US. Axent...hat this sought-after designation has been granted...a therapeutic that will soon be,tested in Phase II... orphan,drug designation for this candidate in bot...
Other Medicine Technology:Brain Training Improves Memory and Attention and the Effects Last 2Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG 2Cystic Fibrosis - Orphan Drug Designation for Innovative Treatment Against Lung Infections by Axentis Pharma AG 3
...e Eppendorf Reference Series 2000 Pipette is a syn...mpact and robust design, and superior operating co...to operate the measuring stroke and blow-out as we...ipette/tip" system ensures utmost accuracy and pre...
Pipetman F100
Finnpipette Fixed Volume, 100ul
Ovation BioNatural Pipette, two-stroke, fixed volume, 20L
Medicine Products: